| Net Cash Provided by (Used in) Operating Activities |
$-2,998,000 |
USD |
-237% |
Q3 2025 |
Q3 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$3,911,000 |
USD |
635% |
Q3 2025 |
Q3 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$12,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
490,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
10,670,392 |
shares |
-49.6% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$924,000 |
USD |
-73.6% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$471,000 |
USD |
-40.2% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$8,768,000 |
USD |
10.5% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$7,790,000 |
USD |
18.7% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$464,000 |
USD |
-49.4% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$83,000 |
USD |
-2.35% |
Q1 2024 |
Q1 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.03 |
pure |
0% |
Q1 2024 |
Q1 2024 |
| Deferred Income Tax Expense (Benefit) |
$-393,000 |
USD |
-181% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$8,867,000 |
USD |
11.9% |
Q4 2024 |
FY 2024 |
| Amortization of Intangible Assets |
$715,000 |
USD |
-0.56% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$8,932,000 |
USD |
10.5% |
Q4 2024 |
FY 2024 |